Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
1999 May 01;1271:9-18. doi: 10.1038/sj.bjp.0702488.
Show Gene links
Show Anatomy links
Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921.
Pugsley MK, Goldin AL.
???displayArticle.abstract???
RSD 921 is a novel, structurally unique, class I Na+ channel blocking drug under development as a local anaesthetic agent and possibly for the treatment of cardiac arrhythmias. The effects of RSD 921 on wild-type heart, skeletal muscle, neuronal and non-inactivating IFMQ3 mutant neuronal Na+ channels expressed in Xenopus laevis oocytes were examined using a two-electrode voltage clamp. RSD 921 produced similarly potent tonic block of all three wild-type channel isoforms, with EC50 values between 35 and 47 microM, whereas the EC50 for block of the IFMQ3 mutant channel was 110+5.5 microM. Block of Na+ channels by RSD 921 was concentration and use-dependent, with marked frequency-dependent block of heart channels and mild frequency-dependent block of skeletal muscle, wild-type neuronal and IFMQ3 mutant channels. RSD 921 produced a minimal hyperpolarizing shift in the steady-state voltage-dependence of inactivation of all three wild-type channel isoforms. Open channel block of the IFMQ3 mutant channel was best fit with a first order blocking scheme with k(on) equal to 0.11+/-0.012x10(6) M(-1) s(-1) and k(off) equal to 12.5+/-2.5 s(-1), resulting in KD of 117+/-31 microM. Recovery from open channel block occurred with a time constant of 14+/-2.7 s(-1). These results suggest that RSD 921 preferentially interacts with the open state of the Na+ channel, and that the drug may produce potent local anaesthetic or anti-arrhythmic action under conditions of shortened action potentials, such as during anoxia or ischaemia.
Armstrong,
Destruction of sodium conductance inactivation in squid axons perfused with pronase.
1973, Pubmed
Armstrong,
Destruction of sodium conductance inactivation in squid axons perfused with pronase.
1973,
Pubmed Auld,
A neutral amino acid change in segment IIS4 dramatically alters the gating properties of the voltage-dependent sodium channel.
1990,
Pubmed
,
Xenbase Bailey,
The electrophysiologic basis for cardiac electrical activity: normal and abnormal.
1981,
Pubmed Barrett,
A model of myocardial ischemia for the simultaneous assessment of electrophysiological changes and arrhythmias in intact rabbits.
1997,
Pubmed Bean,
Lidocaine block of cardiac sodium channels.
1983,
Pubmed Bennett,
On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain.
1995,
Pubmed
,
Xenbase Cahalan,
Local anesthetic block of sodium channels in normal and pronase-treated squid giant axons.
1978,
Pubmed Cascio,
Electrophysiologic changes in ischemic ventricular myocardium: I. Influence of ionic, metabolic, and energetic changes.
1995,
Pubmed Clark,
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives.
1988,
Pubmed Clark,
PD117302: a selective agonist for the kappa-opioid receptor.
1988,
Pubmed Goldin,
Preparation of RNA for injection into Xenopus oocytes.
1992,
Pubmed
,
Xenbase Grant,
The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.
1996,
Pubmed Hille,
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.
1977,
Pubmed HODGKIN,
A quantitative description of membrane current and its application to conduction and excitation in nerve.
1952,
Pubmed Hondeghem,
Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.
1977,
Pubmed Isom,
Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif.
1995,
Pubmed
,
Xenbase Isom,
Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel.
1992,
Pubmed
,
Xenbase Kallen,
Primary structure and expression of a sodium channel characteristic of denervated and immature rat skeletal muscle.
1990,
Pubmed Kléber,
Extracellular K+ and H+ shifts in early ischemia: mechanisms and relation to changes in impulse propagation.
1987,
Pubmed Kontis,
Site-directed mutagenesis of the putative pore region of the rat IIA sodium channel.
1993,
Pubmed
,
Xenbase Lansman,
Blockade of current through single calcium channels by Cd2+, Mg2+, and Ca2+. Voltage and concentration dependence of calcium entry into the pore.
1986,
Pubmed Martin,
Pharmacology of opioids.
1983,
Pubmed Pugsley,
Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.
1998,
Pubmed Pugsley,
Antiarrhythmic effects of U-50,488H in rats subject to coronary artery occlusion.
1992,
Pubmed Pugsley,
Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
1992,
Pubmed Pugsley,
Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
1993,
Pubmed Pugsley,
An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
1994,
Pubmed Pugsley,
Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramil.
1995,
Pubmed Pugsley,
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
1998,
Pubmed
,
Xenbase Ragsdale,
Molecular determinants of state-dependent block of Na+ channels by local anesthetics.
1994,
Pubmed
,
Xenbase Ragsdale,
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
1996,
Pubmed Sanchez-Chapula,
Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells.
1983,
Pubmed Sheridan,
Quantification of state-dependent drug interactions with the sodium channel.
2000,
Pubmed Smith,
Functional analysis of the rat I sodium channel in xenopus oocytes.
1998,
Pubmed
,
Xenbase Strichartz,
An integrated view of the molecular toxinology of sodium channel gating in excitable cells.
1987,
Pubmed Trimmer,
Primary structure and functional expression of a mammalian skeletal muscle sodium channel.
1989,
Pubmed
,
Xenbase Valenzuela,
Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels.
1996,
Pubmed Walker,
Determination of an arylacetamide antiarrhythmic in rat blood and tissues using reversed-phase high-performance liquid chromatography.
1996,
Pubmed West,
A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation.
1992,
Pubmed
,
Xenbase Wong,
Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart--an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis.
1990,
Pubmed
